BCAL Diagnostics Joins Sydney Knowledge Hub And Sydney Mass Spectrometry - The University Of Sydney
Jayne Shaw Represents BCAL Diagnostics at Heads Over Heels in Melbourne
Jayne Shaw and Peter Beaumont (Litmus) Represent BCAL Diagnostics And Win "Win The Future" Contest For International Entrepreneurs in Oceania Programme
Ron Philips and Amani Batarseh Share BCAL Diagnostics Progress
Dr Peter French took to the stage to represent BCAL Dx at the final global round of the 1776 Challenge Cup. This follows BCAL Dx’s successful regional round in Singapore earlier this year.
BCAL Dx was one of 60 finalists in the global round and one of only five companies to progress through to the global round from the Asia-Pacific regional finals.
The Challenge has taken place over the last six months, in 45 cities around the world. Judges had to select from over 1000 startups to progress through to the regional finals, culminating in the global finals with only a handful organisations – of which BCAL Dx was one.
The Challenge was an effective networking opportunity for BCAL Dx, with the opportunity to meet a number of connectors and potential investment partners with a specific interest in medical biotechnology. BCAL Dx was also hosted by the staff of the Australian Embassy, where we discussed the expanding biotech market and how to leverage Australia-US relations in this space.
1776 is a global incubator and seed fund helping startups transform industries that impact millions of lives every day—education, energy & sustainability, health, transportation and cities.
BCAL Dx successfully secured patents in Australia and Japan. BCAL Dx has an exclusive global license to the blood testing technology from the University of Louisville (UoL) in the US. We have been working with the UoL over the last three years to prosecute the patents. In May 2016, the Japanese patent was granted and in September 2016 the Australian patent was granted. We look forward to updating you soon on the granting of the US and Europe patents.
NEXT GENERATION OF MEDICAL INNOVATORS
Health Minister Jillian Skinner congratulated 12 outstanding medical researchers as they graduated from the 2015 Medical Device Commercialisation Training Program.
19 November 2015
BCAL Dx has just signed a $700,000 research contract with University of Kentucky to undertake blind trials on invasive ductal cancer and to determine the accuracy of the test on other breast cancers.
A simple diagnostic blood test for breast cancer
Cancer researcher Dharmica Mistry wins this year’s NSW Young Woman of the Year award. Read more